NervGen Pharma Corp. (NGEN)

2.08 +0.08 (+4.00%) USD  |  NASDAQ  |  Aug 25, 13:15
More

NervGen Pharma EV to Revenues

EV to Revenues Chart

View EV to Revenues for NGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to Revenues Chart
Start Trial

Historical EV to Revenues Data

View and export this data back to . Start Trial.
Date Value

EV to Revenues Range, Past 5 Years

View EV to Revenues Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to Revenues Benchmarks

View EV to Revenues Benchmarks
Start Trial
InMed Pharmaceuticals, Inc. Upgrade
Milestone Pharmaceuticals, Inc. Upgrade
Clearmind Medicine, Inc. --
Lexaria Bioscience Corp. Upgrade
Target Group, Inc. (Canada) Upgrade

EV to Revenues Related Metrics

EV to CFO Upgrade
EV to Free Cash Flow Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade